ReviewCurrent opinion in lipidology2025

Orticumab: the potential to harness oxidized LDL to reduce coronary inflammation with plaque-targeted therapy.

Christopher J Farina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.